Wuhan Keqian Biology Co.,Ltd (688526.SS)
- Previous Close
16.14 - Open
16.00 - Bid 16.47 x --
- Ask 16.48 x --
- Day's Range
15.96 - 16.54 - 52 Week Range
11.00 - 19.56 - Volume
3,232,968 - Avg. Volume
3,645,562 - Market Cap (intraday)
7.682B - Beta (5Y Monthly) 0.65
- PE Ratio (TTM)
18.94 - EPS (TTM)
0.87 - Earnings Date --
- Forward Dividend & Yield 0.43 (2.66%)
- Ex-Dividend Date May 22, 2024
- 1y Target Est
--
Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. The company offers vaccines for pigs, poultry, and pets, as well as diagnostic reagents. Wuhan Keqian Biology Co.,Ltd was founded in 2001 and is based in Wuhan, China.
www.kqbio.comRecent News: 688526.SS
View MorePerformance Overview: 688526.SS
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688526.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688526.SS
View MoreValuation Measures
Market Cap
7.52B
Enterprise Value
6.22B
Trailing P/E
18.55
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.60
Price/Book (mrq)
1.85
Enterprise Value/Revenue
6.34
Enterprise Value/EBITDA
13.34
Financial Highlights
Profitability and Income Statement
Profit Margin
40.08%
Return on Assets (ttm)
6.11%
Return on Equity (ttm)
9.93%
Revenue (ttm)
988.13M
Net Income Avi to Common (ttm)
396.08M
Diluted EPS (ttm)
0.87
Balance Sheet and Cash Flow
Total Cash (mrq)
1.31B
Total Debt/Equity (mrq)
0.17%
Levered Free Cash Flow (ttm)
--